PAPSS2
protein-coding3'-phosphoadenosine 5'-phosphosulfate synthase 2
Gene summary
Sulfation is a common modification of endogenous (lipids, proteins, and carbohydrates) and exogenous (xenobiotics and drugs) compounds. In mammals, the sulfate source is 3'-phosphoadenosine 5'-phosphosulfate (PAPS), created from ATP and inorganic sulfate. Two different tissue isoforms encoded by different genes synthesize PAPS. This gene encodes one of the two PAPS synthetases. Defects in this gene cause the Pakistani type of spondyloepimetaphyseal dysplasia. Two alternatively spliced transcript variants that encode different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~88.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019666
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0019666
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0019666
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0019666
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0019666
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0018662
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Endocrine; Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: The condition may include endocrinological manifestations such as premature pubarche
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PAPSS2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001015880.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 72 | 2 | 75 | ||
| missense | 3 | 1 | 151 | 7 | 2 | 164 |
| nonsense | 13 | 3 | 16 | |||
| start loss | 0 | |||||
| frameshift | 10 | 6 | 2 | 18 | ||
| splice donor/acceptor (+/-2bp) | 3 | 4 | 6 | 13 | ||
| Total | 29 | 14 | 160 | 79 | 4 | 286 |
Highest pathogenic variant AF is 0.0006004253
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001015880.1 | 13 | MANE Select | |
| Ensembl | ENSP00000406157.1 | 13 | MANE Select | |
| RefSeq | NP_004661.2 | 12 | Standard | |
| Ensembl | ENSP00000354436.4 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Selenocompound metabolism - Homo sapiens (human)
- Purine metabolism - Homo sapiens (human)
- Sulfur metabolism - Homo sapiens (human)
- Sulfate/Sulfite Metabolism
- Sulfite oxidase deficiency
Biological Process
- sulfate assimilation
- skeletal system development
- blood coagulation
- phosphorylation
- 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process
Molecular Function
- adenylylsulfate kinase activity
- sulfate adenylyltransferase (ATP) activity
- ATP binding
- nucleotidyltransferase activity
Cellular Component
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000456849
- Coding exons
- 13
- Length
- 88093
- Individuals with no LoFs
- 125684
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 64
- Defined
- 125748
- p
- 0.000255
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.461 | 327 | 351 | 0.931 | 0.0000211 | 4062 |
| Missense (PolyPhen) | 133 | 154.13 | 0.8629 | 1731 | ||
| Synonymous | -0.957 | 144 | 130 | 1.11 | 0.00000759 | 1217 |
| Loss of Function | 1.75 | 20 | 30.4 | 0.658 | 0.00000174 | 346 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00074 | 0.00074 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00026 | 0.00025 | rare |
| South Asian | 0.00043 | 0.00042 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Bifunctional enzyme with both ATP sulfurylase and APS kinase activity, which mediates two steps in the sulfate activation pathway. The first step is the transfer of a sulfate group to ATP to yield adenosine 5'-phosphosulfate (APS), and the second step is the transfer of a phosphate group from ATP to APS yielding 3'-phosphoadenylylsulfate (PAPS: activated sulfate donor used by sulfotransferase). In mammals, PAPS is the sole source of sulfate; APS appears to be only an intermediate in the sulfate- activation pathway. May have a important role in skeletogenesis during postnatal growth (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.168
Intolerance Scores
- LoFtool
- 0.891
- RVIS EVS
- -0.33
- RVIS percentile EVS
- 30.74
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.929
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |